Local consolidative therapy (LCT) to improve progression-free survival (PFS) in patients with oligometastatic non-small cell lung cancer (NSCLC) who receive induction systemic therapy (IST): Results of a multi-institutional phase II randomized study
Statements Author contributions HL: Conceptualization, Methodology, Visualization, Writing original draft, Writing review & editing, Funding acquisition
Similarly, maintenance of tissue oxygenation is highly dependent upon the balance between eryptosis and hematopoiesis [211]
10 It has been speculated that because oral administration of GSH leads to its inactivation by peptidases, it should not be possible to significantly increase plasma GSH concentrations with oral administration
Enhanced Potency: Higher bioavailability and more dramatic results compared to topical application
FIGURE 4 This is complicated because as a polar, charged tripeptide, transport of GSH is significantly inhibited by the blood-brain barrier (BBB), thus limiting effective delivery to brain-resident immune cells such as microglia which are central drivers of neuroinflammatory pathology ( As many treatments for neurological conditions have been hampered by limited permeability of the BBB, significant emphasis has been placed on research directed towards advanced drug delivery methods (Zha et al., 2024